BACKGROUND: Because the clinical course of human infections with hantaviruses can vary from subclinical to fatal, rapid and reliable detection of hantaviruses is essential. To date, the diagnosis of hantavirus infection is based mainly on serologic assays, and the detection of hantaviral RNA by the commonly used reverse transcription (RT)-PCR is difficult because of high sequence diversity of hantaviruses and low viral loads in clinical specimens. METHODS: We developed 5 real-time RT-PCR assays, 3 of which are specific for the individual European hantaviruses Dobrava, Puumala, or Tula virus. Two additional assays detect the Asian species Hantaan virus together with Seoul virus and the American species Andes virus together with Sin Nombre virus. Pyrosequencing was established to provide characteristic sequence information of the amplified hantavirus for confirmation of the RT-PCR results or for a more detailed virus typing. RESULTS: The real-time RT-PCR assays were specific for the respective hantavirus species and optimized to run on 2 different platforms, the LightCycler and the ABI 7900/7500. Each assay showed a detection limit of 10 copies of a plasmid containing the RT-PCR target region, and pyrosequencing was possible with 10 to 100 copies per reaction. With this assay, viral genome could be detected in 16 of 552 (2.5%) specimens of suspected hantavirus infections of humans and mice. CONCLUSIONS: The new assays detect, differentiate, and quantify hantaviruses in clinical specimens from humans and from their natural hosts and may be useful for in vitro studies of hantaviruses.
BACKGROUND: Because the clinical course of human infections with hantaviruses can vary from subclinical to fatal, rapid and reliable detection of hantaviruses is essential. To date, the diagnosis of hantavirus infection is based mainly on serologic assays, and the detection of hantaviral RNA by the commonly used reverse transcription (RT)-PCR is difficult because of high sequence diversity of hantaviruses and low viral loads in clinical specimens. METHODS: We developed 5 real-time RT-PCR assays, 3 of which are specific for the individual European hantaviruses Dobrava, Puumala, or Tula virus. Two additional assays detect the Asian species Hantaan virus together with Seoul virus and the American species Andes virus together with Sin Nombre virus. Pyrosequencing was established to provide characteristic sequence information of the amplified hantavirus for confirmation of the RT-PCR results or for a more detailed virus typing. RESULTS: The real-time RT-PCR assays were specific for the respective hantavirus species and optimized to run on 2 different platforms, the LightCycler and the ABI 7900/7500. Each assay showed a detection limit of 10 copies of a plasmid containing the RT-PCR target region, and pyrosequencing was possible with 10 to 100 copies per reaction. With this assay, viral genome could be detected in 16 of 552 (2.5%) specimens of suspected hantavirus infections of humans and mice. CONCLUSIONS: The new assays detect, differentiate, and quantify hantaviruses in clinical specimens from humans and from their natural hosts and may be useful for in vitro studies of hantaviruses.
Authors: Boris Klempa; Peter T Witkowski; Elena Popugaeva; Brita Auste; Lamine Koivogui; Elisabeth Fichet-Calvet; Thomas Strecker; Jan Ter Meulen; Detlev H Krüger Journal: J Virol Date: 2012-01-25 Impact factor: 5.103
Authors: Sandy Bauherr; Filip Larsberg; Annett Petrich; Hannah Sabeth Sperber; Victoria Klose-Grzelka; Madlen Luckner; Walid Azab; Matthias Schade; Chris Tina Höfer; Maik Joerg Lehmann; Peter T Witkowski; Detlev H Krüger; Andreas Herrmann; Roland Schwarzer Journal: J Virol Date: 2020-07-01 Impact factor: 5.103
Authors: Aleksander Michalski; Marcin Niemcewicz; Agata Bielawska-Drózd; Anna Nowakowska; Jerzy Gaweł; Grzegorz Pitucha; Justyna Joniec; Katarzyna Zielonka; Anna Marciniak-Niemcewicz; Janusz Kocik Journal: Vector Borne Zoonotic Dis Date: 2014-06-05 Impact factor: 2.133
Authors: I Christova; M Pishmisheva; I Trifonova; N Vatev; M Stoycheva; M Tiholova; D Igova; M Baev; R Karagyaurova; U Prokopova Journal: Wien Klin Wochenschr Date: 2017-02-22 Impact factor: 1.704
Authors: Jie Liu; Caroline Ochieng; Steve Wiersma; Ute Ströher; Jonathan S Towner; Shannon Whitmer; Stuart T Nichol; Christopher C Moore; Gilbert J Kersh; Cecilia Kato; Christopher Sexton; Jeannine Petersen; Robert Massung; Christine Hercik; John A Crump; Gibson Kibiki; Athanasia Maro; Buliga Mujaga; Jean Gratz; Shevin T Jacob; Patrick Banura; W Michael Scheld; Bonventure Juma; Clayton O Onyango; Joel M Montgomery; Eric Houpt; Barry Fields Journal: J Clin Microbiol Date: 2015-10-21 Impact factor: 5.948
Authors: Maria Eugenia Dieterle; Carles Solà-Riera; Chunyan Ye; Samuel M Goodfellow; Eva Mittler; Ezgi Kasikci; Steven B Bradfute; Jonas Klingström; Rohit K Jangra; Kartik Chandran Journal: Elife Date: 2021-07-06 Impact factor: 8.140